Entity Common Stock, Shares Outstanding of ELITE PHARMACEUTICALS INC /NV/ from Q2 2011 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q3 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Entity Common Stock, Shares Outstanding for the quarter ending 14 Nov 2025 was 1,074,496,422, a 0.58% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,074,496,422 +6,223,314 +0.58% 14 Nov 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 1,068,463,108 +190,000 +0.02% 27 Jun 2025 10-K 30 Jun 2025 2025 FY
Q4 2024 1,068,273,108 +50,491,909 +5% 13 Feb 2025 10-Q 13 Feb 2025 2025 Q3
Q3 2024 1,068,273,108 +54,358,027 +5.4% 14 Nov 2024 10-Q 14 Nov 2024 2025 Q2
Q2 2024 1,068,273,108 +54,358,027 +5.4% 26 Jun 2024 10-K 01 Jul 2024 2024 FY
Q4 2023 1,017,781,199 +3,866,118 +0.38% 14 Feb 2024 10-Q 14 Feb 2024 2024 Q3
Q3 2023 1,013,915,081 0 0% 14 Nov 2023 10-Q 14 Nov 2023 2024 Q2
Q2 2023 1,013,915,081 +2,633,093 +0.26% 20 Jun 2023 10-K/A 31 Jul 2023 2023 FY
Q4 2022 1,013,915,081 +2,633,093 +0.26% 14 Feb 2023 10-Q 14 Feb 2023 2023 Q3
Q3 2022 1,013,915,081 14 Nov 2022 10-Q 14 Nov 2022 2023 Q2
Q2 2022 1,011,281,988 +2,105,236 +0.21% 23 Jun 2022 10-K 29 Jun 2022 2022 FY
Q4 2021 1,011,281,988 +2,105,236 +0.21% 11 Feb 2022 10-Q 14 Feb 2022 2022 Q3
Q2 2021 1,009,176,752 +168,772,385 +20% 07 Jun 2021 10-K 14 Jun 2021 2021 FY
Q4 2020 1,009,176,752 +169,986,082 +20% 11 Feb 2021 10-Q 16 Feb 2021 2021 Q3
Q3 2020 1,009,176,752 +176,334,692 +21% 10 Nov 2020 10-Q 16 Nov 2020 2021 Q2
Q2 2020 840,404,367 +12,015,866 +1.5% 24 Jun 2020 10-K 29 Jun 2020 2020 FY
Q4 2019 839,190,670 +18,690,531 +2.3% 04 Feb 2020 10-Q 10 Feb 2020 2020 Q3
Q3 2019 832,842,060 +13,352,309 +1.6% 05 Nov 2019 10-Q 12 Nov 2019 2020 Q2
Q2 2019 828,388,501 +24,749,884 +3.1% 07 Jun 2019 10-K 21 Jun 2019 2019 FY
Q4 2018 820,500,139 +28,983,213 +3.7% 06 Feb 2019 10-Q 11 Feb 2019 2019 Q3
Q3 2018 819,489,751 +30,687,924 +3.9% 02 Nov 2018 10-Q 09 Nov 2018 2019 Q2
Q2 2018 803,638,617 +28,083,939 +3.6% 07 Jun 2018 10-K 14 Jun 2018 2018 FY
Q4 2017 791,516,926 -126,381,514 -14% 02 Feb 2018 10-Q 09 Feb 2018 2018 Q3
Q3 2017 788,801,827 -116,860,962 -13% 02 Nov 2017 10-Q 09 Nov 2017 2018 Q2
Q2 2017 775,554,678 +49,068,028 +6.8% 07 Jun 2017 10-K 14 Jun 2017 2017 FY
Q4 2016 917,898,440 +222,729,506 +32% 01 Feb 2017 10-Q 09 Feb 2017 2017 Q3
Q3 2016 905,662,789 +220,906,510 +32% 04 Nov 2016 10-Q 09 Nov 2016 2017 Q2
Q2 2016 726,486,650 +65,563,707 +9.9% 07 Jun 2016 10-K 15 Jun 2016 2016 FY
Q4 2015 695,168,934 04 Feb 2016 10-Q 09 Feb 2016 2016 Q3
Q3 2015 684,756,279 +88,143,844 +15% 05 Nov 2015 10-Q 30 Dec 2015 2016 Q2
Q2 2015 660,922,943 +92,880,880 +16% 03 Aug 2015 10-Q 30 Dec 2015 2016 Q1
Q3 2014 596,612,435 +88,674,966 +17% 04 Nov 2014 10-Q 14 Nov 2014 2015 Q2
Q2 2014 568,042,063 +173,461,890 +44% 20 Jun 2014 10-K 30 Jun 2014 2014 FY
Q4 2013 618,411,948 +261,690,979 +73% 03 Feb 2014 10-Q 17 Feb 2015 2015 Q3
Q3 2013 507,937,469 +157,600,209 +45% 04 Nov 2013 10-Q 14 Nov 2013 2013 Q2
Q2 2013 394,580,173 +48,363,561 +14% 13 Jun 2013 10-K 21 Jun 2013 2012 FY
Q4 2012 356,720,969 +88,739,222 +33% 06 Feb 2013 10-Q 14 Feb 2013 2012 Q3
Q3 2012 350,337,260 +88,213,194 +34% 08 Nov 2012 10-Q 14 Nov 2012 2012 Q2
Q2 2012 346,216,612 +99,104,204 +40% 22 Jun 2012 10-K 29 Jun 2012 2011 FY
Q4 2011 267,981,747 30 Jan 2012 10-Q 14 Feb 2012 2011 Q3
Q3 2011 262,124,066 31 Oct 2011 10-Q 14 Nov 2011 2011 Q2
Q2 2011 247,112,408 10 Aug 2011 10-Q/A 19 Aug 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.